Microstructure and antioxidative capacity of the microalgae mutant Chlorella PY-ZU1 during Tilmicosin (cas 108050-54-0) removal from wastewater under 15% CO2
-
Add time:08/25/2019 Source:sciencedirect.com
The response mechanisms of microalgal mutant Chlorella PY-ZU1 cells were investigated in their removal of antibiotic Tilmicosin (cas 108050-54-0) from wastewater under 15% CO2. Low concentrations (0.01–2 mg L−1) of tilmicosin in wastewater stimulated the growth of microalgal cells, whereas high concentrations (5–50 mg L−1) of tilmicosin significantly inhibited cell growth. When initial tilmicosin concentration increased from 0 to 50 mg L−1, fractal dimension of microalgal cells monotonically increased from 1.36 to 1.62 and cell size monotonically decreased from 4.86 to 3.75 μm. In parallel, malondialdehyde content, which represented the degree of cellular oxidative damage, monotonically increased from 1.92 × 10−7 to 7.07 × 10−7 nmol cell−1. Superoxide dismutase activity that represented cellular antioxidant capacity first increased from 2.59 × 10−4 to the peak of 6.60 × 10−4 U cell−1, then gradually decreased to 2.39 × 10−4 U cell−1. The maximum tilmicosin removal efficiency of 99.8% by Chlorella PY-ZU1 was obtained at the initial tilmicosin concentration of 50 mg L−1.
We also recommend Trading Suppliers and Manufacturers of Tilmicosin (cas 108050-54-0). Pls Click Website Link as below: cas 108050-54-0 suppliers
Prev:Microbiological toxicity of Tilmicosin (cas 108050-54-0) on human colonic microflora in chemostats
Next:ResearchEffects of oral Tilmicosin (cas 108050-54-0) on health and performance in newly received beef heifers) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Original ResearchEffects of Tilmicosin (cas 108050-54-0) Phosphate Administration on Echocardiographic Parameters in Healthy Donkeys (Equus asinus): An Experimental Study08/29/2019
- Effects of nasal instillation of a nitric oxide-releasing solution or parenteral administration of Tilmicosin (cas 108050-54-0) on the nasopharyngeal microbiota of beef feedlot cattle at high-risk of developing respiratory tract disease08/28/2019
- Astragalus polysaccharides alleviate Tilmicosin (cas 108050-54-0)-induced toxicity in rats by inhibiting oxidative damage and modulating the expressions of HSP70, NF-kB and Nrf2/HO-1 pathway08/27/2019
- ResearchEffects of oral Tilmicosin (cas 108050-54-0) on health and performance in newly received beef heifers08/26/2019
- Microbiological toxicity of Tilmicosin (cas 108050-54-0) on human colonic microflora in chemostats08/24/2019
- Minimum ignition energy of medicinal powder – Florfenicol and Tilmicosin (cas 108050-54-0)08/23/2019
- Preparation and evaluation of Tilmicosin (cas 108050-54-0) microspheres and lung-targeting studies in rabbits08/22/2019
- Removal of combined antibiotic (florfenicol, tylosin and Tilmicosin (cas 108050-54-0)) during anaerobic digestion and their relative effect08/21/2019